Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NRL001 in Faecal Incontinence
NCT01656720Phase 2Completed
- Sponsor
- Norgine
- Start
- Feb 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of Methoxamine in fecal incontinence (FI), sponsored by Norgine. Started Feb 2012; status: completed.
02
Drugs
Methoxamine
03
Conditions
fecal incontinence (FI)
Beyond the preview
Go deeper on NCT01656720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01656720.